C9157 – Injection, tofersen, 1 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9157
- Long description
- Injection, tofersen, 1 mg
- Short description
- Inj, tofersen, 1 mg
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- October 1, 2023
- Last change
- January 1, 2024 – No change
- Termination date
- December 31, 2023
Frequently asked questions
What is HCPCS code C9157?
C9157 is a HCPCS Level II code for injection, tofersen, 1 mg. It was discontinued on December 31, 2023.
Does Medicare cover C9157?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9149 – Injection, teplizumab-mzwv, 5 mcg
- C9150 – Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- C9151 – Injection, pegcetacoplan, 1 mg
- C9152 – Injection, aripiprazole, (abilify asimtufii), 1 mg
- C9153 – Injection, amisulpride, 1 mg
- C9154 – Injection, buprenorphine extended-release (brixadi), 1 mg
- C9155 – Injection, epcoritamab-bysp, 0.16 mg
- C9156 – Flotufolastat f 18, diagnostic, 1 millicurie
- C9158 – Injection, risperidone, (uzedy), 1 mg
- C9159 – Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
- C9160 – Injection, daxibotulinumtoxina-lanm, 1 unit
- C9161 – Injection, aflibercept hd, 1 mg
- C9162 – Injection, avacincaptad pegol, 0.1 mg
- C9163 – Injection, talquetamab-tgvs, 0.25 mg
- C9164 – Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- C9165 – Injection, elranatamab-bcmm, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.